https://biotechmorning.com/news/centanafadine-adhd-fda-decision-otsuka Biotech Morning en 2026-07-25T14:14:30.781Z The First New Kind of ADHD Drug in Years Is Waiting on the FDA's Call https://biotechmorning.com/news/genentech-490-million-deal-layoffs Biotech Morning en 2026-07-25T14:13:40.691Z Genentech's $490 Million Shopping Spree Has a Dark Side https://biotechmorning.com/news/car-t-prevent-myeloma-before-it-starts Biotech Morning en 2026-07-25T14:12:42.595Z What If You Could Kill Cancer Before It Even Starts? https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-2 Biotech Morning en 2026-07-24T14:28:25.309Z The FDA Just Opened the Door to Medicines Built for One Person https://biotechmorning.com/news/eplontersen-attr-cardiomyopathy-trial-failure Biotech Morning en 2026-07-24T14:27:32.461Z The Heart Drug That Should Have Worked — But Didn't https://biotechmorning.com/news/lilly-retatrutide-obesity-cardiovascular-miss Biotech Morning en 2026-07-24T14:26:39.264Z Lilly's Next Obesity Blockbuster Just Hit a Wall It Didn't See Coming https://biotechmorning.com/news/sclc-ris-rez-survival-benefit Biotech Morning en 2026-07-24T14:25:43.947Z The Cancer That Broke Every Drug That Tried. Until Now. https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-2 Biotech Morning en 2026-07-24T14:24:53.667Z Sarepta's Worst Week: A Black Box, 500 Pink Slips, and a Stock in Crisis https://biotechmorning.com/news/car-t-solid-tumor-breakthrough-china-approval Biotech Morning en 2026-07-24T14:23:59.896Z CAR-T Just Broke Through the Wall That Stopped It for a Decade https://biotechmorning.com/news/novartis-myricx-billion-dollar-adc-deal Biotech Morning en 2026-07-24T14:23:12.061Z Novartis Just Dropped $1.1 Billion on a Company With Zero Approved Drugs https://biotechmorning.com/news/crispr-casgevy-approved-toddlers-sickle-cell Biotech Morning en 2026-07-24T14:22:14.185Z CRISPR Just Got Cleared for Toddlers. Yes, Toddlers. https://biotechmorning.com/news/pfizer-seagen-sigvotatug-vedotin-nsclc-failure Biotech Morning en 2026-07-24T14:21:19.827Z Pfizer Spent $43 Billion on an ADC Empire. One of Its Crown Jewels Just Cracked. https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition-10-billion-2 Biotech Morning en 2026-07-24T14:20:29.867Z AbbVie Just Bet $10.9 Billion on a Company That Didn't Exist Three Years Ago